Skip to Main Content


Skip Nav Destination

Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.

J Exp Med (1978) 147 (3): 629–644.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal